296 related articles for article (PubMed ID: 37153591)
1. New pairings and deorphanization among the atypical chemokine receptor family - physiological and clinical relevance.
Szpakowska M; D'Uonnolo G; Luís R; Alonso Bartolomé A; Thelen M; Legler DF; Chevigné A
Front Immunol; 2023; 14():1133394. PubMed ID: 37153591
[TBL] [Abstract][Full Text] [Related]
2. GPR182 is a broadly scavenging atypical chemokine receptor influencing T-independent immunity.
Melgrati S; Gerken OJ; Artinger M; Radice E; Szpakowska M; Chevigné A; D'Uonnolo G; Antonello P; Thelen S; Pelczar P; Legler DF; Thelen M
Front Immunol; 2023; 14():1242531. PubMed ID: 37554323
[TBL] [Abstract][Full Text] [Related]
3. Large chemokine binding spectrum of human and mouse atypical chemokine receptor GPR182 (ACKR5).
Bonnavion R; Liu S; Kawase H; Roquid KA; Offermanns S
Front Pharmacol; 2023; 14():1297596. PubMed ID: 38026988
[TBL] [Abstract][Full Text] [Related]
4. Systematic reassessment of chemokine-receptor pairings confirms CCL20 but not CXCL13 and extends the spectrum of ACKR4 agonists to CCL22.
Meyrath M; Reynders N; Uchański T; Chevigné A; Szpakowska M
J Leukoc Biol; 2021 Feb; 109(2):373-376. PubMed ID: 32480426
[TBL] [Abstract][Full Text] [Related]
5. Nanoluciferase-based methods to monitor activation, modulation and trafficking of atypical chemokine receptors.
Luís R; D'Uonnolo G; Palmer CB; Meyrath M; Uchański T; Wantz M; Rogister B; Janji B; Chevigné A; Szpakowska M
Methods Cell Biol; 2022; 169():279-294. PubMed ID: 35623707
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Atypical Chemokine Receptor Expression in T Cell Subsets.
Pacheco MO; Rocha FA; Aloia TPA; Marti LC
Cells; 2022 Dec; 11(24):. PubMed ID: 36552863
[TBL] [Abstract][Full Text] [Related]
7. Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7.
Szpakowska M; Dupuis N; Baragli A; Counson M; Hanson J; Piette J; Chevigné A
Biochem Pharmacol; 2016 Aug; 114():14-21. PubMed ID: 27238288
[TBL] [Abstract][Full Text] [Related]
8. Atypical chemokine receptors 1, 2, 3 and 4: Expression and regulation in the endometrium during the estrous cycle and pregnancy and with somatic cell nucleus transfer-cloned embryos in pigs.
Han J; Yoo I; Lee S; Jung W; Kim HJ; Hyun SH; Lee E; Ka H
Theriogenology; 2019 Apr; 129():121-129. PubMed ID: 30844653
[TBL] [Abstract][Full Text] [Related]
9. Atlas of the anatomical localization of atypical chemokine receptors in healthy mice.
Melgrati S; Radice E; Ameti R; Hub E; Thelen S; Pelczar P; Jarrossay D; Rot A; Thelen M
PLoS Biol; 2023 May; 21(5):e3002111. PubMed ID: 37159457
[TBL] [Abstract][Full Text] [Related]
10. The diverse and complex roles of atypical chemokine receptors in cancer: From molecular biology to clinical relevance and therapy.
Sjöberg E; Meyrath M; Chevigné A; Östman A; Augsten M; Szpakowska M
Adv Cancer Res; 2020; 145():99-138. PubMed ID: 32089166
[TBL] [Abstract][Full Text] [Related]
11. CXCL10 Is an Agonist of the CC Family Chemokine Scavenger Receptor ACKR2/D6.
Chevigné A; Janji B; Meyrath M; Reynders N; D'Uonnolo G; Uchański T; Xiao M; Berchem G; Ollert M; Kwon YJ; Noman MZ; Szpakowska M
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33801414
[TBL] [Abstract][Full Text] [Related]
12. Atypical chemokine receptors in cancer.
Samus M; Rot A
Cytokine; 2024 Apr; 176():156504. PubMed ID: 38266462
[TBL] [Abstract][Full Text] [Related]
13. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
Morein D; Erlichman N; Ben-Baruch A
Front Immunol; 2020; 11():952. PubMed ID: 32582148
[TBL] [Abstract][Full Text] [Related]
14. Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
Benredjem B; Girard M; Rhainds D; St-Onge G; Heveker N
J Biol Chem; 2017 Jan; 292(1):31-42. PubMed ID: 27875312
[TBL] [Abstract][Full Text] [Related]
15. Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases.
Duval V; Alayrac P; Silvestre JS; Levoye A
Front Endocrinol (Lausanne); 2022; 13():906586. PubMed ID: 35846294
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of ACKR family members in breast cancer using prognostic values.
Yang L; Zhang S; Pu P
Oncol Lett; 2023 Oct; 26(4):425. PubMed ID: 37664667
[TBL] [Abstract][Full Text] [Related]
17. Different contributions of chemokine N-terminal features attest to a different ligand binding mode and a bias towards activation of ACKR3/CXCR7 compared with CXCR4 and CXCR3.
Szpakowska M; Nevins AM; Meyrath M; Rhainds D; D'huys T; Guité-Vinet F; Dupuis N; Gauthier PA; Counson M; Kleist A; St-Onge G; Hanson J; Schols D; Volkman BF; Heveker N; Chevigné A
Br J Pharmacol; 2018 May; 175(9):1419-1438. PubMed ID: 29272550
[TBL] [Abstract][Full Text] [Related]
18. Atypical chemokine receptors: emerging therapeutic targets in cancer.
Torphy RJ; Yee EJ; Schulick RD; Zhu Y
Trends Pharmacol Sci; 2022 Dec; 43(12):1085-1097. PubMed ID: 36307250
[TBL] [Abstract][Full Text] [Related]
19. Role of Atypical Chemokine Receptors in Microglial Activation and Polarization.
Salvi V; Sozio F; Sozzani S; Del Prete A
Front Aging Neurosci; 2017; 9():148. PubMed ID: 28603493
[TBL] [Abstract][Full Text] [Related]
20. The dimeric form of CXCL12 binds to atypical chemokine receptor 1.
Gutjahr JC; Crawford KS; Jensen DR; Naik P; Peterson FC; Samson GPB; Legler DF; Duchene J; Veldkamp CT; Rot A; Volkman BF
Sci Signal; 2021 Aug; 14(696):. PubMed ID: 34404752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
